GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (FRA:4PKB) » Definitions » Institutional Ownership

LAVA Therapeutics NV (FRA:4PKB) Institutional Ownership : 3.68% (As of Dec. 15, 2024)


View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, LAVA Therapeutics NV's institutional ownership is 3.68%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, LAVA Therapeutics NV's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, LAVA Therapeutics NV's Float Percentage Of Total Shares Outstanding is 61.18%.


LAVA Therapeutics NV Institutional Ownership Historical Data

The historical data trend for LAVA Therapeutics NV's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Therapeutics NV Institutional Ownership Chart

LAVA Therapeutics NV Historical Data

The historical data trend for LAVA Therapeutics NV can be seen below:

2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30
Institutional Ownership 0.64 3.57 3.57 3.70 3.65 3.68 3.68 3.68 3.68 3.68

LAVA Therapeutics NV Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


LAVA Therapeutics NV Business Description

Traded in Other Exchanges
Address
Yalelaan 62, Utrecht, UT, NLD, 3584 CM
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.

LAVA Therapeutics NV Headlines

No Headlines